e-learning
resources
Berlin 2001
Sunday 23.09.2001
COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Specific features of phenotypes of polymorphic haptoglobin system in patients with chronic bronchitis and healthy smokers
E. D. Iantchina, T. V. Ivthcik, N. E. Hodgaynce, A. N. Kokosov, N. V. Kuzmenkova, L. N. Karlova, E. A. Kiseleva, V. V. Lim (Saint-Petersburg, Russia)
Source:
Annual Congress 2001 - COPD
Session:
COPD
Session type:
Poster Discussion
Number:
276
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. D. Iantchina, T. V. Ivthcik, N. E. Hodgaynce, A. N. Kokosov, N. V. Kuzmenkova, L. N. Karlova, E. A. Kiseleva, V. V. Lim (Saint-Petersburg, Russia). Specific features of phenotypes of polymorphic haptoglobin system in patients with chronic bronchitis and healthy smokers. Eur Respir J 2001; 16: Suppl. 31, 276
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
A comparison of three different methods for analysing airway resistance in healthy subjects, asthma and chronic obstructive pulmonary disease patients
Source: Eur Respir J 2007; 30: Suppl. 51, 177s
Year: 2007
Can breathing pattern parameters be differentiated between healthy and severe asthma patients?
Source: Annual Congress 2012 - Outcomes and assessment methods in physiotherapy and rehabilitation
Year: 2012
Characterisation of a cohort of asthmatics with severe concordant eosinophilic disease according to their IgE status
Source: International Congress 2019 – Clinical implications of asthma management
Year: 2019
Overexpression of chitotriosidase and YKL-40 in serum and sputum in healthy smokers and patients with chronic obstructive pulmonary disease
Source: International Congress 2018 – Clinical determinants and biomarkers of COPD
Year: 2018
Usefulness of a panel of sputum markers in the evaluation of lung inflammation and functional impairment in symptomatic smokers and COPD patients
Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases
Year: 2011
Alterations in sputum inflammatory markers during exacerbations for COPD patients with different stable state levels
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019
Effect of one moderate or mild exacerbation on lung function and serum inflammatory markers in ex smokers patients with COPD
Source: Annual Congress 2009 - Cellular-tissue modifications and functional evaluation in COPD patients
Year: 2009
Some local markers indices of saliva inflammation in patients with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 62s
Year: 2004
Proteomic analysis of plasma from COPD patients and smoking control subjects
Source: Annual Congress 2007 - Novel therapeutic targets and disease markers in pulmonary pathology
Year: 2007
Inflammatory markers in sputum of patients with cough variant asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 584s
Year: 2002
Patterns of lung function abnormalities in smokers as possible manifestation of "early" COPD phenotypes
Source: Annual Congress 2012 - New issues in pulmonary function
Year: 2012
Differences in microsatellite DNA level between asthma and chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: 472-478
Year: 2006
Micro-RNA expression in induced sputum of smokers and patients with chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Genetics of obstruction
Year: 2010
Associations between inflammatory endotypes and phenotypes of obesity at young patients with bronchial asthma
Source: Virtual Congress 2020 – Asthma management: role of biomarkers and comorbidities
Year: 2020
Overlapping biologic exacerbation clusters in asthma and chronic obstructive pulmonary disease have distinct sputum mediator and microbiome profiles
Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Year: 2018
Lymphocyte subpopulations in serum in patients with nonallergic asthma and chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 288s
Year: 2006
Characterization of COPD phenotype: comparison of the perceptual response to exercise in emphysema and chronic bronchitis patients
Source: Annual Congress 2008 - Respiratory muscles in disease
Year: 2008
The genetic markers (HLA system) of steroid-resistance in severe bronchial asthma patients
Source: Eur Respir J 2006; 28: Suppl. 50, 678s
Year: 2006
Differences in migrating neutrophils from patients with COPD compared with healthy smokers and non smokers and patients with alpha 1 antitrypsin deficiency
Source: Annual Congress 2010 - Novel mechanisms in COPD
Year: 2010
The prevalence of subtypes of type-2 inflammation in a real-life population of patients with difficult-to-control asthma
Source: International Congress 2019 – Clinical aspects of airway diseases
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept